A Study of NVL-655 in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
NCT 05384626 Brief Summary Phase 1/2, dose escalation and expansion study designed…
Read more arrow_forwardNCT 05384626 Brief Summary Phase 1/2, dose escalation and expansion study designed…
Read more arrow_forwardNCT 05552976 Brief Summary The purpose of the study is to…
Read more arrow_forwardNCT 06106945 Brief Summary This is a Phase I/II, modular, open-label,…
Read more arrow_forwardNCT 05666700 Brief Summary This clinical trial will investigate the in vivo…
Read more arrow_forwardNCT 03275103 Brief Summary This is a phase I, multicenter, open-label, dose-escalation…
Read more arrow_forwardNCT 04643002 Brief Summary The purpose of this umbrella study is to…
Read more arrow_forwardNCT 03486873 Brief Summary The purpose of this study is to…
Read more arrow_forwardNCT 06092580 Brief Summary The aims of this clinical trial are (1)…
Read more arrow_forwardNCT 03212404 Brief Summary CK-301 (cosibelimab) is a fully human monoclonal antibody…
Read more arrow_forwardNCT 06179511 Brief Summary This is a modular, multicentre, open-label, Phase…
Read more arrow_forward